Cervical Cancer Screening (PDQ®)–Health Professional Version

Go to Patient Version

CERVICAL CANCER

SECTIONS

Changes to This Summary (03/29/2018)

Overview

Added Wright et al. as reference 4.

Description of the Evidence

Updated statistics with estimated new cases and deaths for 2018 (cited American Cancer Society as reference 1). Also revised text to state that from 2005 to 2014, overall incidence rates stabilized, and from 2006 to 2015, the death rate decreased by 0.8% per year.

Added Halfon et al. as reference 45.

The Alternative Screening and Treatment Strategies Including Low-Resource Settingssubsection was renamed from Alternative Screening and Treatment Strategies in Low-resource Settings.

Added text to state that a Dutch study among women who participated in the national cervical cancer screening program found that vaginal self-sampling was highly concordant with high-risk human papilloma virus prevalence in physician-collected samples and was both convenient and user friendly; also added that vaginal self-sampling will be offered in the Dutch national screening program for those who do not participate in their routine screening (cited Ketelaars et al. as reference 78).

Evidence of Harm

Added Raffle et al. as reference 4.

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Evidence of Harm

Next section >
About This PDQ Summary